Inquiry Basket
BOC Sciences offers comprehensive one-stop antibody-drug conjugate research and evaluation services.
BOC Sciences provides customers with comprehensive one-stop services for all aspects of antibody-drug conjugate research and evaluation, from antibody modification and conjugation, cytotoxin development, cytotoxin-linker synthesis, ADC manufacturing, to ADC characterization and evaluation various stages.
Jan 7, 2025
As of January 18, 2025, a total of 17 ADC drugs have been approved worldwide, several of which have demonstrated promising clinical efficacy and are expected to become blockbuster drugs. According to Frost & Sullivan data, the global ADC market is projected to grow to $64.7 billion by 2030 (+23% CAGR).
Jan 21, 2025
Over the years, significant advances in antibody engineering, linker chemistry, and cytotoxic drug development have gradually overcome many of the initial barriers, progressing from the early exploratory stages to clinical breakthroughs and the current era of second- and third-generation innovations.
